177 related articles for article (PubMed ID: 6273981)
1. HPLC analysis of erythrocyte pyrimidine-5'-nucleotidase inhibition by lead.
Rocco RM; Smart JL; Brown DR; Blumberg JB
Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):127-36. PubMed ID: 6273981
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte nucleotides from control and lead-treated rabbits.
Swanson MS; Angle CR; Stohs SJ; Rovang KS
Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):353-61. PubMed ID: 6245437
[TBL] [Abstract][Full Text] [Related]
3. Relationship between inhibition of erythrocyte pyrimidine 5'-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead.
Tomokuni K; Ichiba M; Hirai Y; Hasegawa T; Sugimoto K
Int Arch Occup Environ Health; 1988; 60(6):431-6. PubMed ID: 2842263
[TBL] [Abstract][Full Text] [Related]
4. Prediction of blood lead by HPLC assay of erythrocyte pyrimidine 5'-nucleotidase.
Cook LR; Angle CR; Kubitschek CE; Stohs SJ
J Anal Toxicol; 1987; 11(1):39-42. PubMed ID: 3029506
[TBL] [Abstract][Full Text] [Related]
5. A simplified method for determining erythrocyte pyrimidine 5'-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure.
Sakai T; Ushio K
Br J Ind Med; 1986 Dec; 43(12):839-44. PubMed ID: 3026435
[TBL] [Abstract][Full Text] [Related]
6. Response of erythrocyte pyrimidine 5'-nucleotidase (P5N) activity in workers exposed to lead.
Ichiba M; Tomokuni K
Br J Ind Med; 1988 Oct; 45(10):718-9. PubMed ID: 2848571
[No Abstract] [Full Text] [Related]
7. Erythrocyte arginase, pyrimidine 5'-nucleotidase (P5N), and deoxypyrimidine 5'-nucleotidase (dP5N) as indices of lead exposure.
Cook LR; Angle CR; Stohs SJ
Br J Ind Med; 1986 Jun; 43(6):387-90. PubMed ID: 3013277
[TBL] [Abstract][Full Text] [Related]
8. Comparison of pyrimidine 5'nucleotidase activity in erythrocytes of sheep, dogs, cats, horses, calves, and Mongolian gerbils.
George JW; Duncan JR; Mahaffey EA
Am J Vet Res; 1983 Oct; 44(10):1968-70. PubMed ID: 6314858
[TBL] [Abstract][Full Text] [Related]
9. Comparison of inhibition of erythrocyte pyrimidine 5'-nucleotidase and delta-aminolevulinic acid dehydratase by lead.
Tomokuni K; Ichiba M
Toxicol Lett; 1988 Feb; 40(2):159-63. PubMed ID: 2829393
[TBL] [Abstract][Full Text] [Related]
10. Low level lead and inhibition of erythrocyte pyrimidine nucleotidase.
Angle CR; McIntire MS
Environ Res; 1978 Oct; 17(2):296-302. PubMed ID: 233817
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte pyrimidine 5'-nucleotidase and deoxynucleotidase isozymes: metallosensitivity and kinetics.
Cook L; Kubitschek C; Stohs S; Angle C
Drug Chem Toxicol; 1988 Jun; 11(2):195-213. PubMed ID: 2841083
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte pyrimidine 5'-nucleotidase activity in workers exposed to lead, mercury or cadmium.
Mohammed-Brahim B; Buchet JP; Lauwerys R
Int Arch Occup Environ Health; 1985; 55(3):247-52. PubMed ID: 2987134
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of lead, mercury and cadmium on the enzymic activity of red-blood cell pyrimidine 5'-nucleotidase.
Mohammed-Brahim B; Buchet JP; Bernard A; Lauwerys R
Toxicol Lett; 1984 Feb; 20(2):195-9. PubMed ID: 6320500
[TBL] [Abstract][Full Text] [Related]
14. Effects of low-level lead exposure on pyrimidine 5'-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5'-nucleotidase in the pathogenesis of lead-induced anemia.
Paglia DE; Valentine WN; Dahlgren JG
J Clin Invest; 1975 Nov; 56(5):1164-9. PubMed ID: 1184742
[TBL] [Abstract][Full Text] [Related]
15. Effect of lead chelation therapy with EDTA in children on erythrocyte pyrimidine 5'-nucleotidase and with cytidine triphosphate levels.
Swanson MS; Angle CR; Stohs SJ
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):497-500. PubMed ID: 6293983
[TBL] [Abstract][Full Text] [Related]
16. Isozymes of human erythrocyte pyrimidine 5'-nucleotidase--chromatographic separation and their properties.
Hirono A; Fujii H; Miwa S
Jpn J Exp Med; 1985 Feb; 55(1):37-44. PubMed ID: 2993713
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte pyrimidine 5'-nucleotidase inhibition by acute lead exposure in neonatal rats.
Konantakieti C; Beuthin FC; Louis-Ferdinand RT
J Biochem Toxicol; 1986 Sep; 1(3):51-9. PubMed ID: 2856073
[TBL] [Abstract][Full Text] [Related]
18. Studies on erythrocyte pyrimidine 5'-nucleotidase (P5N) test and its evaluation in workers occupationally exposed to lead.
Ichiba M; Tomokuni K
Int Arch Occup Environ Health; 1990; 62(4):305-10. PubMed ID: 2379961
[TBL] [Abstract][Full Text] [Related]
19. Effect of lead exposure on some biological indices related to porphyrin metabolism and the activity of erythrocyte pyrimidine 5'-nucleotidase in the mice.
Tomokuni K; Ichiba M; Hirai Y
Arch Toxicol; 1989; 63(1):23-8. PubMed ID: 2545181
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte pyrimidine-5'-nucleotidase activity as a sensitive indicator of lead exposure.
Torrance JD; Mills W; Kilroe-Smith TA; Smith AN
S Afr Med J; 1985 May; 67(21):850-2. PubMed ID: 2986302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
